|
[1] National Workshop on Fatty Liver and Alcoholic Liver Disease,Chinese Society of Hepatology,Chinese Medical Association;Fatty Liver Expert Committee,Chinese Medical Doctor Association. Guidelines of prevention and treatment for alcoholic liver disease:A 2018 update[J]. J Clin Hepatol,2018,34(5):939-946.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组，中国医师协会脂肪性肝病专家委员会．酒精性肝病防治指南(2018年更新版)[J]．临床肝胆病杂志，2018,34(5):939-946.
|
|
[2] DANAN G,BENICHOU C. Causality assessment of adverse reactions to drug-I. A novel method based on the conclusions of international consensus meetings:Application to drug-induced liver injury[J]. J Clin Epidemiol,1993,46(11):1323-1330.
|
|
[3] Drug-induced Liver Disease Study Group,Chinese Society of Hepatology,Chinese Medical Association. Guidelines for the management of drug-induced liver injury[J]. J Clin Hepatol,2015,31(11):1752-1769.(in Chinese)中华医学会肝病学分会药物性肝病学组．药物性肝损伤诊治指南[J]．临床肝胆病杂志，2015,31(11):1752-1769.
|
|
[4] Branch of Hepatobiliary Diseases,China Association of Chinese Medicine,Branch of Chinese Patent Medicine,China Association of Chinese Medicine. Guidelines for the clinical management of herb-induced liver injury[J]. J Clin Hepatol,2016,32(5):835-843.(in Chinese)中华中医药学会肝胆病分会，中华中医药学会中成药分会．中草药相关肝损伤临床诊疗指南[J]．临床肝胆病杂志，2016,32(5):835-843.
|
|
[5] National Workshop on Fatty Liver and Alcoholic Liver Disease,Chinese Society of Hepatology,Chinese Medical Association;Fatty Liver Expert Committee,Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease:A 2018 update[J]. J Clin Hepatol,2018,34(5):947-957.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组，中国医师协会脂肪性肝病专家委员会．非酒精性脂肪性肝病防治指南(2018年更新版)[J]．临床肝胆病杂志，2018,34(5):947-957.
|
|
[6] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association; Chinese Society of Infectious Diseases,Chinese Medical Association. Consensus on the diagnosis and management of autoimmune hepatitis(2015)[J]. J Clin Hepatol,2016,32(1):9-22.(in Chinese)中华医学会肝病学分会，中华医学会消化病学分会，中华医学会感染病学分会．自身免疫性肝炎诊断和治疗共识(2015)[J]．临床肝胆病杂志，2016,32(1):9-22.
|
|
[7] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association; Chinese Society of Infectious Diseases,Chinese Medical Association. Consensus on the diagnosis and management of primary biliary cirrhosis(cholangitis)(2015)[J]. J Clin Hepatol,2015,31(12):1980-1988.(in Chinese)中华医学会肝病学分会，中华医学会消化病学分会，中华医学会感染病学分会．原发性胆汁性肝硬化(又名原发性胆汁性胆管炎)诊断和治疗共识(2015)[J]．临床肝胆病杂志，2015,31(12):1980-1988.
|
|
[8] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association; Chinese Society of Infectious Diseases,Chinese Medical Association. Consensus on the diagnosis and management of primary sclerosing cholangitis(2015)[J]. J Clin Hepatol,2016,32(1):23-31.(in Chinese)中华医学会肝病学分会，中华医学会消化病学分会，中华医学会感染病学分会．原发性硬化性胆管炎诊断和治疗专家共识(2015)[J]．临床肝胆病杂志，2016,32(1):23-31.
|
|
[9] Cooperative Group of Investigation of Alcohol Dependence and Related Issues. A collaborative study on alcohol dependence among the populations of 4 occupations in 9 cities of China:I.Methodology and prevalence rate[J]. Chin Mental Health J,1992,6(3):112-115,142.(in Chinese)酒精依赖与有关问题调查协作组．中国9个城市4种职业人群酒精依赖协作研究(一)方法学及患病率[J]．中国心理卫生杂志，1992,6(3):112-115,142.
|
|
[10] Cooperative Group of Investigation of Alcohol Dependence and Related Issues. A collaborative study on alcohol dependence among the populations of 4 occupations in 9 cities of China:II.Harm of alcohol dependence on mental,physical,and social functions[J]. Chin Mental Health J,1992,6(3):116-117,136.(in Chinese)酒精依赖与有关问题调查协作组．中国9个城市4种职业人群酒精依赖协作研究(二)酒精依赖对精神、躯体和社会功能的危害[J]．中国心理卫生杂志，1992,6(3):116-117,136.
|
|
[11] CHEN SL,MENG XD,WANG BY,et al. An epidemiologic survey of alcoholic liver disease in some cities of Liaoning Province(2010)[J]. J Prac Hepatol,2010,13(6):428-435.(in Chinese)陈士林，孟晓丹，王炳元，等．辽宁省部分城市酒精性肝病流行现状调查[J]．实用肝脏病杂志，2010,13(6):428-430,435.
|
|
[12] WANG H,MA L,YIN Q,et al. Prevalence of alcoholic liver disease and its association with socioeconomic status in north-eastern China[J]. Alcohol Clin Exp Res,2014,38(4):1035-1041.
|
|
[13] HUANG SL,DAI SQ,ZHANG XH,et al. An epidemiological investigation of alcoholic liver disease in Hunan Province,China[J]. J Chin Physician,2005,7(3):426-427.(in Chinese)黄顺玲，戴水奇，张雪红，等．湖南省酒精性肝病流行病学调查概况[J]．中国医师杂志，2005,7(3):426-427.
|
|
[14] LIU JJ,JIAO Y,ZHANG HP. An epidemiological investigation of alcoholic liver disease[J]. J Mod Med Health,2010,26(10):1590-1591.(in Chinese)刘江静，焦洋，张宏萍．酒精性肝病的流行病学调查[J]．现代医药卫生，2010,26(10):1590-1591.
|
|
[15] LU XL,TAO M,LUO JY,et al. Epidemiology of alcoholic liver diseases in Xi’an[J]. World Chin J Dig,2003,11(6):719-722.(in Chinese)鲁晓岚，陶明，罗金燕，等．西安酒精性肝病流行病学[J]．世界华人消化杂志，2003,11(6):719-722.
|
|
[16] National Cooperative Group of Alcoholic Liver Disease Investigation. Management of malignant biliary hilar obstruction with multiple stents[J]. Chin J Dig,2007,27(4):231-234.(in Chinese)全国酒精性肝病调查协作组．全国酒精性肝病的多中心调查分析[J]．中华消化杂志，2007,27(4):231-234.
|
|
[17] SHEN T,LIU Y,SHANG J,et al. Incidence and etiology of drug-induced liver injury in mainland China[J]. Gastroenterology,2019,156(8):2230-2241.
|
|
[18] NAVARRO VJ,BARNHART HX,BONKOVSKY HL,et al. 167herbal and dietary supplement induced hepatotoxicity in the U. S.[J]. Gastroenterology,2012,142(5):S-41.
|
|
[19] AKEMI T,YASUNI N,KOUICHI T,et al. Comparison of liver biopsy findings with the digestive disease week Japan 2004scale for diagnosis of drug-induced liver injury[J]. Mediators Inflamm,2015,2015:1-9.
|
|
[20] CHALASANI N,HAYASHI P,BONKOVSKY H,et al. ACG Clinical Guideline:The diagnosis and management of idiosyncratic drug-induced liver injury[J]. Am J Gastroenterol,2014,109(7):950-966,quiz 967.
|
|
[21] Chinese Society of Tuberculosis,Chinese Medical Association.Expert recommendations on the diagnosis and treatment of liver injury induced by antitubercular agents[J]. Chin J Tuberc Respir Dis,2013,36(10):732-736.(in Chinese)中华医学会结核病学分会．抗结核药所致药物性肝损伤诊断与处理专家建议[J]．中华结核和呼吸杂志，2013,36(10):732-736.
|
|
[22] LI YJ,QI H,SHEN C,et al. Research advances in susceptibility to hepatotoxicity induced by antitubercular agents[J]. Chin J Evid Based Pediatr,2016,11(4):309-316.(in Chinese)李颖佳，綦辉，申晨，等．抗结核药物致肝毒性易感性研究进展[J]．中国循证儿科杂志，2016,11(4):309-316.
|
|
[23] WANG JY,TSAI CH,LEE YL,et al. Gender-dimorphic impact of PXR Genotype and haplotype on hepatotoxicity during antituberculosis treatment[J]. Medicine(Baltimore),2015,94(24):e982.
|
|
[24] ZHU JZ,ZHOU QY,WANG YM,et al. Prevalence of fatty liver disease and the economy in China:A systematic review[J].World J Gastroenterol,2015,21(18):5695-5706.
|
|
[25] LEUNG JC,LOONG TC,WEI JL,et al. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients[J]. Hepatology,2017,65(1):54-64.
|
|
[26] WANG Y,WANG B,SHEN F,et al. Body mass index and risk of primary liver cancer:A meta-analysis of prospective studies[J]. Oncologist,2012,17(11):1461-1468.
|
|
[27] WONG VW,WONG GL,YEUNG JC,et al. Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram:A prospective cohort study[J]. Hepatology,2016,63(3):754-763.
|
DownLoad: